UPDATE : Wednesday, April 24, 2019
상단여백
OECD guideline OKs Korean-developed eye irritation test
Eye irritation test developed in Korea has won the approval as the test gui...
by Lee Hye-seon  |  2019-04-22 15:33
라인
Gene therapies’ potentials, challenges explained
Can Korea lead the global market of innovative gene therapies?Healthcare ex...
by Jeong Sae-im  |  2019-04-22 11:46
라인
Seoul Medical Center to export public healthcare platform to Turkmenistan
Seoul Medical Center said Friday that it has signed an agreement to export ...
by Lee Han-soo  |  2019-04-19 17:48
라인
‘Darzalex as another weapon against multiple myeloma’
Janssen Korea’s Darzalex (ingredient: daratumumab) is effective for heavily...
by Park Gi-taek  |  2019-04-19 15:39
라인
Why is TissueGene CEO silent about Invossa mislabeling?
Noh Moon-jong, CEO of Kolon TissueGene, is the key person to clarify why In...
by Jeong Sae-im  |  2019-04-19 14:37
라인
[Special]‘K-Medi’s overseas advance will contribute to health of global citizens’
The Division of Global Health Care Affairs at the Ministry of Health and We...
by Kwak Sung-sun  |  2019-04-19 14:22
라인
JVM to supply pharmaceutical packaging machine to Russia
JVM, a subsidiary of Hanmi Pharmaceutical, said Friday that it has signed a...
by Lee Han-soo  |  2019-04-19 14:09
라인
Dong-A to export birth control pill to Vietnam
Dong-A Pharmaceutical said Friday it has agreed to export Roman K, a birth ...
by Lee Han-soo  |  2019-04-19 13:41
라인
Diabetic patients have higher risk of suffering from other illnesses
Researchers at Gangnam Severance Hospital have found that diabetes patients...
by Lee Han-soo  |  2019-04-18 16:02
라인
CJ HealthCare’s new gastric acid blocker K-Cab sold ₩ 1.5 billion in March
CJ HealthCare’s K-Cab Tab., the nation’s 30th novel drug, recorded 1.53 bil...
by Jeong Sae-im  |  2019-04-18 15:27
라인
‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
In the past, HIV and AIDS were known as deadly diseases that could take awa...
by Kim Yun-mi  |  2019-04-18 15:20
라인
Novartis’ new macular degeneration drug has to compete against colon cancer drug Avastin. Why?
Novartis’ new treatment for macular degeneration might have to fight agains...
by Kim Yun-mi  |  2019-04-18 14:42
라인
‘How Korean pharma companies can succeed in US’
With most Korean pharmaceutical and biosimilar companies aiming to launch t...
by Lee Han-soo  |  2019-04-18 14:41
라인
Kolon desperate to keep Invossa license amid suspicion of data fabrication
Kolon Life Science might get its sales license of Invossa-K revoked, as the...
by Lee Hye-seon  |  2019-04-18 11:16
라인
IVI-led consortium wins Fleming Fund's grant
An international consortium led by the International Vaccine Institute (IVI...
by Lee Han-soo  |  2019-04-18 11:15
라인
Severance Hospital succeeds in combined lung-liver transplant
Severance Hospital said Tuesday that it has successfully conducted a lung-l...
by Lee Han-soo  |  2019-04-17 18:00
라인
Small drugmakers celebrate export deals worth ₩18.3 billion
The Ministry of Health and Welfare and the Korea Health Industry Developmen...
by Kwak Sung-sun  |  2019-04-17 17:20
라인
THAAD backlash almost over: Chinese patients to Korea up 18 %
The number of Chinese patients visiting Korea rebounded in 2018, signaling ...
by Kwak Sung-sun  |  2019-04-17 16:00
라인
Patients to file class-action suit against Kolon over Invossa
Local patients who got Invossa-K injection for arthritis treatment will pur...
by Jeong Sae-im  |  2019-04-17 14:58
라인
‘Invossa lacked clinical evidence to be commercialized’
Kolon Life Science’s gene therapy Invossa-K for arthritis treatment had ina...
by Jeong Sae-im  |  2019-04-17 12:45
여백
여백
여백
Back to Top